Andrew Bhatt

Andrew Bhatt is a leading researcher on aspirin and colorectal cancer prevention. His large-scale observational studies and randomized trial analyses have provided robust evidence that regular aspirin use reduces colorectal cancer incidence and mortality. He investigates molecular mechanisms including COX-2 inhibition, platelet inactivation, and effects on Wnt signaling through which aspirin exerts anti-cancer effects. He participates in major CRC prevention trials and contributes to clinical guidelines on aspirin chemoprevention in high-risk individuals.